Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 547

Results For "NIT"

5826 News Found

Lancet study confirms Johnson & Johnson Ebola vaccine safe
Drug Approval | September 16, 2021

Lancet study confirms Johnson & Johnson Ebola vaccine safe

Data show the vaccine regimen induced neutralising antibody responses in nearly all participating adults and children 21 days after the second dose. Adults receiving booster shots two years after the initial vaccination regimen showed strong immune responses


DRDO places orders for oxygen generators with 10 companies
Public Health | September 16, 2021

DRDO places orders for oxygen generators with 10 companies

Godrej and Boyce and Isgec Engineering have confirmed receiving the orders


Maharashtra to publicise health tips on social media
Public Health | September 16, 2021

Maharashtra to publicise health tips on social media

Between 30-40 per cent of Covid-19 patients are either obese or diabetic


U.S. FDA approves Thermo Fisher Scientific’s Oncomine Dx target test
Medical Device | September 16, 2021

U.S. FDA approves Thermo Fisher Scientific’s Oncomine Dx target test

It approves tissue-based NGS companion diagnostic for Takeda's targeted therapy for NSCLC patients with EGFR Exon20 insertion mutations


Roche set to acquire long-term partner TIB Molbiol
Biotech | September 16, 2021

Roche set to acquire long-term partner TIB Molbiol

The deal is expected to close in the fourth quarter of 2021 and will enable Roche to further expand the portfolio. TIB Molbiol excels in ultra-rapid assay development of emerging infectious diseases


NCLT approves amalgamation of Lincoln Parenteral with Lincoln Pharma
News | September 16, 2021

NCLT approves amalgamation of Lincoln Parenteral with Lincoln Pharma

The amalgamation is expected to bring in a lot of synergies in terms of operational efficiency and productivity for the combined entity


Glenmark’s PMS study allays concerns on use of Favipiravir for Covid-19 treatment
News | September 15, 2021

Glenmark’s PMS study allays concerns on use of Favipiravir for Covid-19 treatment

These were the findings of the Post Marketing Surveillance (PMS), study of Favipiravir (FabiFlu) on over 1000 patients


BLS empanelled to process Ayushman Bharat cards
Public Health | September 15, 2021

BLS empanelled to process Ayushman Bharat cards

The National Health Authority (NHA) aims to deliver 10 crore Ayushman Bharat cards in this financial year and extend free hospitalization benefits to 50 lakh people in a quarter


WPO and ECR release ‘Packaging Design for Recycling Guide’
Packaging | September 15, 2021

WPO and ECR release ‘Packaging Design for Recycling Guide’

The document is a global recommendation for circular packaging design. It will be updated and adapted to changes in the collection, sorting and recycling technology, as well as to future material development


World’s first clinical trial for a rare headache disorder
Biotech | September 15, 2021

World’s first clinical trial for a rare headache disorder

The trial will evaluate the efficacy of psilocybin in Short-lasting Unilateral Neuralgiform Headache Attacks (SUNHA). The data is expected in early 2022